You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
AstraZeneca
McKinsey
Boehringer Ingelheim

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

ELSPAR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for ELSPAR

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of WashingtonPhase 2
Jazz PharmaceuticalsPhase 2
Baxalta US Inc.Phase 2

See all ELSPAR clinical trials

Recent Litigation for ELSPAR

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Ravgen, Inc. v. PerkinElmer Inc.2020-06-01
Ravgen, Inc. v. Natera, Inc.2020-06-01
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all ELSPAR litigation

PTAB Litigation
PetitionerDate
2017-11-17
2016-09-09
2013-01-28

See all ELSPAR litigation

Patent Text Search: US Patents for ELSPAR

These patents were identified by searching patent claims

Supplementary Protection Certificates for ELSPAR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C960031 Netherlands   Start Trial PRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621
SZ 27/2007 Austria   Start Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL
960031 Netherlands   Start Trial 960031, 20101020, EXPIRES: 20110620
SPC/GB07/031 United Kingdom   Start Trial PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
91325 Luxembourg   Start Trial PRODUCT NMAE. LUMINITY; REGISTRATION DATE: 20060920
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Moodys
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.